USPTO serial 79342738
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rosaleen H. Chou
Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorKnobbe, Martens, Olson & Bear, LLPIrvine, CA 92614| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, pharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical use, namely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis | ACTIVE | — |
| 009 | Downloadable or recorded software for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors | ACTIVE | — |
| 042 | Research, development, technical design and scientific testing services, namely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial services, namely providing laboratory testing in clinical trials; tests in laboratories, namely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; research, development, technical design, testing, consultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biology | ACTIVE | — |
| 044 | Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicine, namely in the fields of immuno-oncology and cancer research; genetic analysis services, namely in the fields of immuno-oncology and cancer research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 22, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 22, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 9, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 21, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |